NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Drug Encapsulation


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Celsion and Yakult Honsha Announce Treatment of First Patient in Japan in Celsion's Global Phase III ThermoDox(R) Trial for Primary Liver Cancer
2009 NOV 9 ... registration." "ThermoDox holds the potential to become a significant drug in our pharmaceutical portfolio and an important addition to our oncology franchise," ... control and improve quality of life. ThermoDox is a proprietary heat-activated liposomal encapsulation of doxorubicin, an approved and frequently used oncology drug for the treatment of a ...
Subject: Celsion Corporation
Price: $3.00
*
Celsion Reports Third Quarter 2009 Financial Results and Business Update
2009 NOV 23 ... Celsion Corporation (NASDAQ: CLSN), a leading oncology drug development company, announced financial results for the third quarter ended September ... made in the commercialization of ThermoDox®, Celsion's heat activated liposomal encapsulation of doxorubicin for the treatment of hepatocellular carcinoma (HCC), the most common form ...
Subject: Celsion Corporation
Price: $3.00
*
Celsion's Global Phase III ThermoDox(R) Trial Approved by SFDA in China
2009 NOV 1 ... CLSN) announced that it has received official approval from China's State Food and Drug Administration ("SFDA") for its Clinical Trial Application for ThermoDox that permits ... control and improve quality of life. ThermoDox is a proprietary heat-activated liposomal encapsulation of doxorubicin, an approved and frequently used oncology drug for the treatment of a ...
Subject: Celsion Corporation
Price: $3.00
*
Data from Donghua University provide new insights into controlled release
2009 NOV 2 ... The researchers concluded: "The results indicated that the incorporated drug and/or proteins in composite fibrous mats made from electrospinning could be control ... type of tissue engineering scaffold or drugs delivery carrier with the capability of encapsulation and controlled release drugs. In this study, Rhodamine B and Bovine Serum Albumin (BSA) ...
Subject: Controlled Release
Price: $3.00
*
Investigator Meetings Completed in Japan and China for Celsion's Global Phase III ThermoDox(R) Trial for Primary Liver Cancer
2009 NOV 2 ... ineffective in the treatment of primary liver cancer. Celsion is evaluating it's lead drug, ThermoDox, in combination with RFA to improve the outcomes of patients with ... control and improve quality of life. ThermoDox is a proprietary heat-activated liposomal encapsulation of doxorubicin, a commonly used oncology drug for the treatment of a wide range of ...
Subject: Celsion Corporation
Price: $3.00
*
New pharmaceutical research study findings recently were reported by researchers at Hacettepe University
2009 OCT 27 ... Pharmaceutical Research, Hacettepe University. This article was prepared by Drug Law Weekly editors from staff and other reports. Copyright 2009, Drug Law Weekly via ... nanoparticles were characterized through particle size determination, zeta potential, encapsulation efficiency, surface morphology determinations and in vitro release studies. The surface ...
Subject: Pharmaceutical Research
Price: $3.00
*
New pharmaceuticals study findings recently were published by researchers at University of Catania
2009 NOV 2 ... diethyltoluamide and OMC were incorporated into solid lipid nanoparticles, a colloidal drug delivery system, to reduce percutaneous absorption and avoid toxic effects and also ... a synergic effect, indicating that the lipid matrix of nanoparticles guaranteed a high encapsulation of both diethyltoluamide and ONIC. from the in-vitro study demonstrated that the ...
Subject: Pharmaceuticals
Price: $3.00
*
Q Chip to develop biopharmaceutical portfolio based on its established bioencapsulation technology
2009 NOV 16 ... Q Chip, a biopharmaceutical drug delivery company, is developing a range of sustained-release biosimilars using its ... at 80 microns in diameter are injectable using 27-29 needle gauge devices. Encapsulation of biotherapies into bioresorbable microspheres enables sustained and improved drug ...
Subject: Business News
Price: $3.00
*
Recent findings from Chang-Gung University highlight research in life sciences
2009 NOV 2 ... vivo. Animals were subsequently sacrificed, and the bladders were harvested to examine drug accumulation and histology. Ranges of the mean size and zeta potential were 30 similar ... nanoemulsions with Brij 98 exhibited the complete inhibition of cell proliferation. The encapsulation of cisplatin and carboplatin, another derivative of cisplatin, in nanoemulsions resulted ...
Subject: Life Sciences
Price: $3.00
*
Reports summarize antisense technology research from Shanghai Jiao Tong University
2009 OCT 19 ... Republic of China, Shanghai, Antisense Technology, Biotechnology, Clinical Research, Drug Development, Enzyme Research, Gene Therapy, Genetics, Genomics, Histology, Keloid, ... dermal fibroblasts were infected in vitro with modified phosphorothioate and liposome-encapsulation DDR1-antisense oligodeoxynucleotide (ASODN). Northern blot was used to analyze gene ...
Subject: Antisense Technology
Price: $3.00
*
Research from University of Kent has provided new information about pharmaceuticals
2009 OCT 6 ... of microspheres was investigated. The obtained microspheres were analyzed in terms of drug content, particle size and encapsulation efficiency. The morphology of microsphere was ...
Subject: Pharmaceuticals
Price: $3.00
*
Researchers from Fudan University provide details of new studies and findings in the area of drug development
2009 NOV 2 ... were studied in comparison with micelles prepared by dialysis." "Drug encapsulation efficiency (EE) and loading content (LC) of the micelles were evaluated by ...
Subject: Drug Development
Price: $3.00
*
Scientists at Prince of Songkla University, Department of Pharmaceutical Technology discuss research in liposomes
2009 NOV 16 ... Changsan and colleagues published the results of their research in the Journal of Drug Targeting (Monitoring safety of liposomes containing rifampicin on respiratory cell ... The liposome suspension had multilamellar nanovesicles with 50% rifampicin encapsulation." "The liposome dry powder comprised particles with a mass median ...
Subject: Liposomes
Price: $3.00
*
Scientists at University of Lodz report research in life sciences
2009 NOV 2 ... indicated that in glutaralfehyde-treated human erythrocytes the elevated level of drug was observed but also the various changes in the organization of the red cells were ... According to recent research published in the journal Toxicology in Vitro, "Encapsulation of antineoplastic drugs within erythrocytes is one of the studied strategies to diminish ...
Subject: Life Sciences
Price: $3.00
*
Studies from China University yield new information about blood substitutes
2009 OCT 12 ... w/o/w method and characterized with regard to their morphology, size, surface charge, drug loading, surface hydrophilicity, and PEG coating efficiency," scientists writing in the ... were evaluated. The HbP prepared were all in the range of 100-200 nm with highest encapsulation efficiency 87.89%, surface charge -10 to -33 mV, static contact angle from 54.25A ...
Subject: Blood Substitutes
Price: $3.00
*
Studies in the area of macromolecular research reported from Carnegie Mellon University
2009 OCT 6 ... fluorescently labeled biomolecules, such as rhodamine B isothiocyanate-dextran used as a drug model. Thiol-derivatized HA (HA-SH) was prepared by carbodiimide-mediated coupling ... polymerization and potential as an injectable biocompatible matrix for cell and protein encapsulation in both tissue engineering and drug delivery applications." Bencherif and ...
Subject: Macromolecular Research
Price: $3.00
*
Study findings from University of California broaden understanding of molecular pharmaceutics
2009 NOV 24 ... Molecular Pharmacology, Molecular Therapies, Therapy, Treatment, Biotechnology, Drug Delivery, Indocyanine Green, Pharmaceuticals, Drugs, Diagnostics, Molecular ... and spleen, as well as the lungs. The circulation kinetics of ICG appeared unaffected by encapsulation; however, the deposition within organs other than the liver suggests a different ...
Subject: Molecular Pharmaceutics
Price: $3.00
*
VitaminSpice Appoints Dr. Richard F. Seelig as Director
2009 NOV 11 ... (308) 385-4991 or visit VitaminSpice.net. Keywords: Qualsec, U.S. Food and Drug Administration, FDA. This article was prepared by Physician Law Weekly ... Sea Salt, Italian Seasoning, Ground Cinnamon and Granulated Garlic. A proprietary micro-encapsulation process keeps the vitamin properties locked inside--even when heated--allowing the food ...
Subject: Qualsec
Price: $3.00
*
Winston S. Kirton and Patrick Ronan Join Digestive Care, Inc. Senior Management Team
2009 NOV 2 ... years of experience and leadership in the pharmaceutical industry and the U.S. Food and Drug Administration (FDA) to DCI at a critical stage of the company's growth and ... of gastric acid resistant digestive enzymes and buffered bile acids through micro encapsulation led to the development of the successful drug product, PANCRECARB® (pancrelipase), ...
Subject: Digestive Care, Inc. DCI
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login